Pradelli, L. and Ascierto, P. (2016) “[Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]”, Farmeconomia. Health economics and therapeutic pathways, 17(3S), pp. 1–32. doi: 10.7175/fe.v17i3S.1279.